165 related articles for article (PubMed ID: 34569870)
21. Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma.
Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
J Clin Oncol; 1987 Aug; 5(8):1205-11. PubMed ID: 3305792
[TBL] [Abstract][Full Text] [Related]
22. Dose-intensive use of cyclophosphamide in ablation of neuroblastoma.
Kushner BH; O'Reilly RJ; LaQuaglia M; Cheung NK
Cancer; 1990 Sep; 66(6):1095-100. PubMed ID: 2400963
[TBL] [Abstract][Full Text] [Related]
23. Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma.
Kushner BH; Kramer K; LaQuaglia MP; Modak S; Yataghene K; Cheung NK
J Clin Oncol; 2004 Dec; 22(24):4888-92. PubMed ID: 15611504
[TBL] [Abstract][Full Text] [Related]
24. N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.
Cheung NK; Kushner BH; LaQuaglia M; Kramer K; Gollamudi S; Heller G; Gerald W; Yeh S; Finn R; Larson SM; Wuest D; Byrnes M; Dantis E; Mora J; Cheung IY; Rosenfield N; Abramson S; O'Reilly RJ
Med Pediatr Oncol; 2001 Jan; 36(1):227-30. PubMed ID: 11464891
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
Bagatell R; Rumcheva P; London WB; Cohn SL; Look AT; Brodeur GM; Frantz C; Joshi V; Thorner P; Rao PV; Castleberry R; Bowman LC
J Clin Oncol; 2005 Dec; 23(34):8819-27. PubMed ID: 16314642
[TBL] [Abstract][Full Text] [Related]
26. Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients.
Kraal KC; Bleeker GM; van Eck-Smit BL; van Eijkelenburg NK; Berthold F; van Noesel MM; Caron HN; Tytgat GA
Eur J Cancer; 2017 May; 76():188-196. PubMed ID: 28329731
[TBL] [Abstract][Full Text] [Related]
27. Application of high-dose rate (60)Co remote after-loading system for local recurrent neuroblastoma.
Sugito K; Furuya T; Kaneda H; Masuko T; Ohashi K; Inoue M; Ikeda T; Koshinaga T; Yagasaki H; Mugishima H; Maebayashi T
J Pediatr Surg; 2011 Nov; 46(11):e25-8. PubMed ID: 22075368
[TBL] [Abstract][Full Text] [Related]
28. Is extensive surgery required for treatment of advanced neuroblastoma?
Kaneko M; Ohakawa H; Iwakawa M
J Pediatr Surg; 1997 Nov; 32(11):1616-9. PubMed ID: 9396539
[TBL] [Abstract][Full Text] [Related]
29. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
30. Treatment results of advanced neuroblastoma with the first Japanese study group protocol. Study Group of Japan for Treatment of Advanced Neuroblastoma.
Kaneko M; Tsuchida Y; Uchino J; Takeda T; Iwafuchi M; Ohnuma N; Mugishima H; Yokoyama J; Nishihira H; Nakada K; Sasaki S; Sawada T; Kawa K; Nagahara N; Suita S; Sawaguchi S
J Pediatr Hematol Oncol; 1999; 21(3):190-7. PubMed ID: 10363851
[TBL] [Abstract][Full Text] [Related]
31. Long-term survivors of advanced neuroblastoma with MYCN amplification: A report of 19 patients surviving disease-free for more than 66 months.
Kawa K; Ohnuma N; Kaneko M; Yamamoto K; Etoh T; Mugishima H; Ohhira M; Yokoyama J; Bessho F; Honna T; Yoshizawa J; Nakada K; Iwafuchi M; Nozaki T; Mimaya J; Sawada T; Nakamura T; Miyata H; Yamato K; Tsuchida Y
J Clin Oncol; 1999 Oct; 17(10):3216-20. PubMed ID: 10506621
[TBL] [Abstract][Full Text] [Related]
32. Outcome of children with relapsed or refractory neuroblastoma: A meta-analysis of ITCC/SIOPEN European phase II clinical trials.
Moreno L; Rubie H; Varo A; Le Deley MC; Amoroso L; Chevance A; Garaventa A; Gambart M; Bautista F; Valteau-Couanet D; Geoerger B; Vassal G; Paoletti X; Pearson AD
Pediatr Blood Cancer; 2017 Jan; 64(1):25-31. PubMed ID: 27555472
[TBL] [Abstract][Full Text] [Related]
33. NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology.
Coze C; Hartmann O; Michon J; Frappaz D; Dusol F; Rubie H; Plouvier E; Leverger G; Bordigoni P; Béhar C; Beck D; Mechinaud F; Bergeron C; Plantaz D; Otten J; Zucker JM; Philip T; Bernard JL
J Clin Oncol; 1997 Dec; 15(12):3433-40. PubMed ID: 9396394
[TBL] [Abstract][Full Text] [Related]
34. Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial.
Goto K; Ohe Y; Shibata T; Seto T; Takahashi T; Nakagawa K; Tanaka H; Takeda K; Nishio M; Mori K; Satouchi M; Hida T; Yoshimura N; Kozuki T; Imamura F; Kiura K; Okamoto H; Sawa T; Tamura T;
Lancet Oncol; 2016 Aug; 17(8):1147-1157. PubMed ID: 27312053
[TBL] [Abstract][Full Text] [Related]
35. [Curative effects of the protocol of CDV combined with CiE as pre-operative chemotherapy in high-risk childhood neuroblastoma].
Feng C; Tang SQ; Wang JW; Liu Y; Yang G
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Nov; 11(11):885-7. PubMed ID: 20113653
[TBL] [Abstract][Full Text] [Related]
36. Prolonged response to oral gefitinib, cyclophosphamide, and topotecan in heavily pretreated relapsed stage 4 neuroblastoma: a case report.
Donfrancesco A; Jenkner A; De Ioris MA; Ilari I; Castellano A; De Laurentis C; Garganese MC; Milano GM; Dominici C
J Pediatr Hematol Oncol; 2007 Nov; 29(11):799-803. PubMed ID: 17984703
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: a report from the Children's Oncology Group.
Zage PE; Kletzel M; Murray K; Marcus R; Castleberry R; Zhang Y; London WB; Kretschmar C;
Pediatr Blood Cancer; 2008 Dec; 51(6):747-53. PubMed ID: 18704922
[TBL] [Abstract][Full Text] [Related]
38. Multiagent chemotherapy for children with advanced neuroblastoma. A comparison of high-dose cyclophosphamide, vincristine and adriamycin therapy with James' therapy plus adriamycin.
Hiyoshi Y; Yano H; Tanaka T; Noguchi A; Horikoshi T; Irie Y
Kurume Med J; 1984; 31(1):1-6. PubMed ID: 6482368
[No Abstract] [Full Text] [Related]
39. Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemia.
Gore SD; Gojo I; Sekeres MA; Morris L; Devetten M; Jamieson K; Redner RL; Arceci R; Owoeye I; Dauses T; Schachter-Tokarz E; Gallagher RE
J Clin Oncol; 2010 Feb; 28(6):1047-53. PubMed ID: 20085935
[TBL] [Abstract][Full Text] [Related]
40. Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study.
Bowman LC; Castleberry RP; Cantor A; Joshi V; Cohn SL; Smith EI; Yu A; Brodeur GM; Hayes FA; Look AT
J Natl Cancer Inst; 1997 Mar; 89(5):373-80. PubMed ID: 9060959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
